NEJM today publishes findings of international trial resulting in recent FDA approval of Abraxane (nab-paclitaxel) for patients with advanced pancreatic cancer.Continue reading
Tag Archives: Pancreatic Cancer
TGen and Scottsdale Healthcare Launch Phase I ‘Thunder God vine’ Trial for Cancer
First patient receives treatment at Virginia G. Piper Cancer Center Clinical TrialsContinue reading
FDA approves drug tested by Scottsdale Healthcare and TGen
Abraxane now part of standard-of-care for patients with advanced pancreatic cancer, following studies at the Virginia G. Piper Cancer Center at Scottsdale Healthcare
Continue reading
U.S. Food and Drug Administration Approves ABRAXANE® in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer
-Approval Based on MPACT Study of ABRAXANE in Combination with Gemcitabine Demonstrating a Clinically Meaningful Increase in Overall Survival-
-First New Treatment Approved for Metastatic Adenocarcinoma of the Pancreas in Nearly 8 Years-Continue reading
Translational Genomics Research Institute (TGen) and Ventana Medical Systems, Inc. join forces to fight cancer
Two of Arizona’s premier biomedical institutions unite to develop critically needed diagnostic biomarkers for cancer
Continue reading